FAS and triple-negative breast carcinoma: Studying triple-negative breast cancer cells, Malleter et al. 24 found that activating Fas with the cleaved form of FasL could promote the migration of these cells via the activation of Yes-1-mediated, EGF-independent EGFR activation and subsequently the activation of the PI3K pathway24.